Are you hoping for this on the NHS?
Yes, through the NHS. Expect no. Rescheduling in 2018 made prescribing lawful and licensed nothing; NICE guideline NG144 recommends against cannabis-based products for chronic pain outside a trial and limits the rest, so NHS bodies do not fund the unlicensed products. The number of NHS prescriptions for unlicensed cannabis products is withheld by the government because it covers fewer than five patients โ it is not "three", it is unpublished. In practice the route is private.
Privately, through a clinic. That is the route that exists: a specialist-led clinic, an initial consultation, usually a multidisciplinary review, then a prescription dispensed by a pharmacy licensed for Schedule 2 drugs. Clinic fees are the clinic's to publish; medicine prices are not published here.